{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T12:47:59Z","timestamp":1780922879106,"version":"3.54.1"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Diagnostic Pathology"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.anndiagpath.2020.151585","type":"journal-article","created":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T07:53:59Z","timestamp":1597391639000},"page":"151585","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Increased CD200 expression in post-transplant lymphoproliferative disorders correlates with an increased frequency of FoxP3(+) regulatory T cells"],"prefix":"10.1016","volume":"48","author":[{"given":"James W.","family":"Vaughan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Horna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Horatiu","family":"Olteanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.anndiagpath.2020.151585_bb0005","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S1471-4906(02)02223-8","article-title":"CD200 and membrane protein interactions in the control of myeloid cells","volume":"23","author":"Barclay","year":"2002","journal-title":"Trends Immunol"},{"issue":"10","key":"10.1016\/j.anndiagpath.2020.151585_bb0010","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.it.2008.07.005","article-title":"Cancer stem cells, CD200 and immunoevasion","volume":"29","author":"Kawasaki","year":"2008","journal-title":"Trends Immunol"},{"issue":"5","key":"10.1016\/j.anndiagpath.2020.151585_bb0015","first-page":"483","article-title":"CD200 and its receptors as targets for immunoregulation","volume":"6","author":"Gorczynski","year":"2005","journal-title":"Curr Opin Investig Drugs"},{"issue":"13","key":"10.1016\/j.anndiagpath.2020.151585_bb0020","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.1182\/blood-2006-06-029355","article-title":"CD200 is a new prognostic factor in multiple myeloma","volume":"108","author":"Moreaux","year":"2006","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.anndiagpath.2020.151585_bb0025","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1365-2141.2010.08555.x","article-title":"CD200 expression in plasma cell myeloma","volume":"153","author":"Olteanu","year":"2011","journal-title":"Br J Haematol"},{"issue":"5","key":"10.1016\/j.anndiagpath.2020.151585_bb0030","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1309\/AJCP38XRRUGSQOVC","article-title":"CD200 (OX-2 membrane glycoprotein) expression in b cell-derived neoplasms","volume":"134","author":"Dorfman","year":"2010","journal-title":"Am J Clin Pathol"},{"issue":"12","key":"10.1016\/j.anndiagpath.2020.151585_bb0035","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1038\/modpathol.2012.129","article-title":"Utility of CD200 immunostaining in the diagnosis of primary mediastinal large B cell lymphoma: comparison with MAL, CD23, and other markers","volume":"25","author":"Dorfman","year":"2012","journal-title":"Mod Pathol"},{"issue":"9","key":"10.1016\/j.anndiagpath.2020.151585_bb0040","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1038\/leu.2012.75","article-title":"Increased CD200 expression in acute myeloid leukemia is linked with an increased frequency of FoxP3+ regulatory T cells","volume":"26","author":"Coles","year":"2012","journal-title":"Leukemia"},{"issue":"9","key":"10.1016\/j.anndiagpath.2020.151585_bb0045","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1038\/leu.2012.77","article-title":"Expression of CD200 on AML blasts directly suppresses memory T-cell function","volume":"26","author":"Coles","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.anndiagpath.2020.151585_bb0050","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","first-page":"453","article-title":"Post-transplant lymphoproliferative disorders","author":"Swerdlow","year":"2017"},{"issue":"2","key":"10.1016\/j.anndiagpath.2020.151585_bb0055","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1053\/j.semdp.2012.08.005","article-title":"Immunosuppressive and immunomodulatory therapy-associated lymphoproliferative disorders","volume":"30","author":"Bagg","year":"2013","journal-title":"Semin Diagn Pathol"},{"issue":"12","key":"10.1016\/j.anndiagpath.2020.151585_bb0060","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.3109\/10428190903315713","article-title":"Predictors of outcome in post-transplant lymphoproliferative disorder: an evaluation of tumor infiltrating lymphocytes in the context of clinical factors","volume":"50","author":"Richendollar","year":"2009","journal-title":"Leuk Lymphoma"},{"issue":"2","key":"10.1016\/j.anndiagpath.2020.151585_bb0065","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1080\/10428190701824536","article-title":"Prognostic impact of tumor infiltrating FOXP3 positive regulatory T cells in diffuse large B-cell lymphoma at diagnosis","volume":"49","author":"Lee","year":"2008","journal-title":"Leuk Lymphoma"},{"issue":"20","key":"10.1016\/j.anndiagpath.2020.151585_bb0070","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.anndiagpath.2020.151585_bb0075","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","article-title":"Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray","volume":"103","author":"Hans","year":"2004","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.anndiagpath.2020.151585_bb0080","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1046\/j.1365-2567.2001.01163.x","article-title":"The unusual distribution of the neuronal\/lymphoid cell surface CD200 (OX2) glycoprotein is conserved in humans","volume":"102","author":"Wright","year":"2001","journal-title":"Immunology"},{"issue":"1","key":"10.1016\/j.anndiagpath.2020.151585_bb0085","doi-asserted-by":"crossref","first-page":"68","DOI":"10.4049\/jimmunol.173.1.68","article-title":"T follicular helper cells express a distinctive transcriptional profile, reflecting their role as non-Th1\/Th2 effector cells that provide help for B cells","volume":"173","author":"Chtanova","year":"2004","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.anndiagpath.2020.151585_bb0090","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/cyto.b.21722","article-title":"CD200 is a useful marker in the diagnosis of chronic lymphocytic leukemia","volume":"96","author":"Mora","year":"2019","journal-title":"Cytometry B Clin Cytom"},{"issue":"9","key":"10.1016\/j.anndiagpath.2020.151585_bb0095","doi-asserted-by":"crossref","first-page":"5595","DOI":"10.4049\/jimmunol.178.9.5595","article-title":"CD200 expression on tumor cells suppresses antitumor immunity: new approaches to cancer immunotherapy","volume":"178","author":"Kretz-Rommel","year":"2007","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.anndiagpath.2020.151585_bb0100","doi-asserted-by":"crossref","first-page":"699","DOI":"10.4049\/jimmunol.180.2.699","article-title":"Blockade of CD200 in the presence or absence of antibody effector function: implications for anti-CD200 therapy","volume":"180","author":"Kretz-Rommel","year":"2008","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.anndiagpath.2020.151585_bb0105","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1517\/14712598.8.1.5","article-title":"Rationale for anti-CD200 immunotherapy in B-CLL and other hematologic malignancies: new concepts in blocking immune suppression","volume":"8","author":"Kretz-Rommel","year":"2008","journal-title":"Expert Opin Biol Ther"},{"issue":"21","key":"10.1016\/j.anndiagpath.2020.151585_bb0110","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1182\/blood.V116.21.2465.2465","article-title":"First-in-human phase I dose escalation study of a humanized anti-CD200 antibody (samalizumab) in patients with advanced stage B cell chronic lymphocytic leukemia (B-CLL) or multiple myeloma (MM)","volume":"116","author":"Mahadevan","year":"2010","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.anndiagpath.2020.151585_bb0115","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/sj.leu.2404559","article-title":"CD200 as a prognostic factor in acute myeloid leukaemia","volume":"21","author":"Tonks","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.anndiagpath.2020.151585_bb0120","first-page":"1","article-title":"Occurrence and prognostic relevance of CD30 expression in post-transplant lymphoproliferative disorders","author":"Vase","year":"2015","journal-title":"Leuk Lymphoma"},{"issue":"6","key":"10.1016\/j.anndiagpath.2020.151585_bb0125","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1093\/ajcp\/aqx097","article-title":"CD30 expression in monomorphic posttransplant lymphoproliferative disorder, diffuse large B-cell lymphoma correlates with greater regulatory T-cell infiltration","volume":"148","author":"Hartley","year":"2017","journal-title":"Am J Clin Pathol"},{"issue":"12","key":"10.1016\/j.anndiagpath.2020.151585_bb0130","doi-asserted-by":"crossref","first-page":"28998","DOI":"10.3390\/ijms161226143","article-title":"Reduced dendritic cells expressing CD200R1 in children with inflammatory bowel disease: correlation with Th17 and regulatory T cells","volume":"16","author":"Elshal","year":"2015","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.anndiagpath.2020.151585_bb0135","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.leukres.2008.08.021","article-title":"Disruption of T cell suppression in chronic lymphocytic leukemia by CD200 blockade","volume":"33","author":"Pallasch","year":"2009","journal-title":"Leuk Res"},{"issue":"9","key":"10.1016\/j.anndiagpath.2020.151585_bb0140","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1097\/01.TP.0000152118.51622.F9","article-title":"Augmented induction of CD4+CD25+ Treg using monoclonal antibodies to CD200R","volume":"79","author":"Gorczynski","year":"2005","journal-title":"Transplantation"}],"container-title":["Annals of Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913420301283?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913420301283?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T20:32:30Z","timestamp":1761078750000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1092913420301283"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":28,"alternative-id":["S1092913420301283"],"URL":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2020.151585","relation":{},"ISSN":["1092-9134"],"issn-type":[{"value":"1092-9134","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased CD200 expression in post-transplant lymphoproliferative disorders correlates with an increased frequency of FoxP3(+) regulatory T cells","name":"articletitle","label":"Article Title"},{"value":"Annals of Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2020.151585","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"151585"}}